We are live on ! Find out more
VXRT

Vaxart
VXRT

Delisted

VXRT was delisted on the 7th of July, 2025.

Back to rankings

17 hedge funds and large institutions have $1.64M invested in Vaxart in 2018 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 2

1.49% less ownership

Funds ownership: 9.08% → 7.6% (-1.5%)

6% less funds holding

Funds holding: 18 → 17 (-1)

25% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 4

52% less capital invested

Capital invested by funds: $3.42M → $1.64M (-$1.78M)

Holders
17
Holders Change
-1
Holders Change %
-5.56%
% of All Funds
0.39%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
4
Reduced
2
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
+$358K
2
Renaissance Technologies
Renaissance Technologies
New York
+$239K
3
PAM
Panagora Asset Management
Massachusetts
+$101K
4
BlackRock
BlackRock
New York
+$52.2K
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$28.7K

Top Sellers

Rank Fund Capital Flow
1
KAM
Krensavage Asset Management
New York
-$1.37M
2
Goldman Sachs
Goldman Sachs
New York
-$55K
3
Vanguard Group
Vanguard Group
Pennsylvania
-$48.6K
4
IA
IFP Advisors
Florida
-$106
Name Holding Trade Value Shares
Change 		Change in
Stake
Renaissance Technologies
1
Renaissance Technologies
New York
$649K +$239K +51,900 +32%
Vanguard Group
2
Vanguard Group
Pennsylvania
$267K -$48.6K -10,542 -11%
AC
3
Armistice Capital
New York
$235K +$358K +77,599 New
BlackRock
4
BlackRock
New York
$157K +$52.2K +11,316 +28%
CCM
5
Carlson Capital Management
Minnesota
$86K – – –
PAM
6
Panagora Asset Management
Massachusetts
$71K +$101K +21,933 +1,434%
Geode Capital Management
7
Geode Capital Management
Massachusetts
$64K +$28.7K +6,225 +41%
GCIA
8
Gabelli & Co Investment Advisers
New York
$57K – – –
RFWA
9
RPg Family Wealth Advisory
Massachusetts
$30.3K – – –
PNC Financial Services Group
10
PNC Financial Services Group
Pennsylvania
$10K – – –
UBS Group
11
UBS Group
Switzerland
$7K +$9.89K +2,146 New
TL
12
TowerView LLC
New York
$6K – – –
RE
13
RBC Europe
United Kingdom
$2.12K – – –
Morgan Stanley
14
Morgan Stanley
New York
$2K +$3.49K +756 New
KAM
15
Krensavage Asset Management
New York
– -$1.37M -256,973 Closed
Goldman Sachs
16
Goldman Sachs
New York
– -$55K -10,399 Closed
IA
17
IFP Advisors
Florida
– -$106 -23 -92%

VXRT Hedge Fund Activity: Q2 2018 in Review

17 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Vaxart (VXRT) for Q2 2018, worth a combined $1.64M — down 52% from $3.42M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of VXRT and 3 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 4 added.

The largest buyer was Armistice Capital, opening a new position worth an estimated $358K. The largest seller was Krensavage Asset Management, exiting entirely with an estimated $1.37M sold.

  • 17 institutional investors held Vaxart (VXRT) as of Q2 2018, down from 18 in Q1 2018.
  • Funds reported $1.64M of Vaxart stock for Q2 2018, down 52% quarter-over-quarter.
  • 3 funds opened new Vaxart positions in Q2 2018 and 4 closed out, a net change of -1 holder.
  • The largest Vaxart buyer in Q2 2018 was Armistice Capital, an estimated $358K added.
  • The largest Vaxart seller in Q2 2018 was Krensavage Asset Management, an estimated $1.37M sold.

Based on aggregated 13F filings for Q2 2018.